Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Clinical trial NCT01767675 · COMPLETED
Trial details
- NCT number
- NCT01767675
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-08
- Primary completion
- 2025-08-26
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.